Olopatadine 1mg/ml Eye Drops
You will answer clinical questions before treatment is considered. Submitting a consultation does not guarantee supply.
Olopatadine 1mg/ml Eye Drops is an eye treatment used for allergic conjunctivitis where clinically appropriate. It contains Olopatadine 1mg/ml.
Suitability depends on your symptoms, medical history, current medicines, allergies, previous treatment and pregnancy or breastfeeding considerations where relevant.
How to use
Use Olopatadine 1mg/ml Eye Drops exactly as directed by your pharmacist, prescriber or the patient information leaflet supplied with the product.
The treatment schedule for allergic conjunctivitis is: Twice daily. Do not change the dose, frequency or duration unless advised by a clinician.
Wash your hands, tilt the head back and place the prescribed drop into the lower conjunctival sac. Avoid touching the dropper tip to the eye, lashes or skin.
Product-specific age restrictions and contact-lens advice apply. Many multidose preparations contain benzalkonium chloride. Persistent pain, visual symptoms or marked unilateral redness requires reassessment rather than continued allergy treatment.
If symptoms of allergic conjunctivitis worsen, do not respond as expected or you develop a serious reaction, stop and seek appropriate clinical advice.
Main Ingredients
Olopatadine 1mg/ml Eye Drops contains Olopatadine 1mg/ml as the main active ingredient or treatment component.
The exact formulation, excipients, device components or inactive ingredients can vary by manufacturer and pack supplied.
Always check the patient information leaflet or product instructions supplied with your specific pack, particularly if you have known allergies or intolerances.
Side Effects & Cautions
Brief stinging, irritation or blurred vision can occur after eye-drop application. Persistent pain, photophobia or reduced vision requires eye assessment.
Product-specific age restrictions and contact-lens advice apply. Many multidose preparations contain benzalkonium chloride. Persistent pain, visual symptoms or marked unilateral redness requires reassessment rather than continued allergy treatment.
Significant eye pain, marked light sensitivity, persistent blurred or reduced vision, trauma, chemical exposure or a very red single eye requires prompt face-to-face assessment rather than routine allergy treatment.
Stop treatment and seek urgent medical help for difficulty breathing, swelling of the face, lips or tongue, collapse or another severe allergic reaction.
Suitability is confirmed through clinical assessment. Prescription medicine is supplied only where clinically appropriate.
Read the official patient information leaflet before using any medicine. The leaflet provides important information on use, cautions, side effects and storage.
Open leaflet on eMC